Emerging roles for Eph receptors and ephrin ligands in immunity

TK Darling, TJ Lamb - Frontiers in immunology, 2019 - frontiersin.org
Eph receptors are the largest family of receptor tyrosine kinases and mediate a myriad of
essential processes in humans from embryonic development to adult tissue homeostasis …

Signaling pathways and therapeutic approaches in glioblastoma multiforme

M Khabibov, A Garifullin… - International …, 2022 - spandidos-publications.com
Glioblastoma multiforme (GBM) is the most aggressive type of primary brain tumor and is
associated with a poor clinical prognosis. Despite the progress in the understanding of the …

A BRCA2 germline mutation and high expression of immune checkpoints in a TNBC patient

Y Han, V Rovella, A Smirnov, OC Buonomo… - Cell Death …, 2023 - nature.com
Triple-negative breast cancer (TNBC) is the most aggressive subtype of mammary
carcinoma. Here, we describe a case of an 81-year-old female diagnosed with ductal triple …

Nose-to-brain delivery of temozolomide-loaded PLGA nanoparticles functionalized with anti-EPHA3 for glioblastoma targeting

L Chu, A Wang, L Ni, X Yan, Y Song, M Zhao, K Sun… - Drug …, 2018 - Taylor & Francis
Glioblastoma is the most common malignant brain tumor. Efficient delivery of drugs targeting
glioblastomas remains a challenge. Ephrin type-A receptor 3 (EPHA3) tyrosine kinase …

Eph receptors in cancer

S Arora, AM Scott, PW Janes - Biomedicines, 2023 - mdpi.com
Eph receptor tyrosine kinases play critical functions during development, in the formation of
tissue and organ borders, and the vascular and neural systems. Uniquely among tyrosine …

The potential role of COVID-19 in progression, chemo-resistance, and tumor recurrence of oral squamous cell carcinoma (OSCC)

A Norouzi, M Liaghat, M Bakhtiyari… - Oral Oncology, 2023 - Elsevier
Numerous studies have revealed that cancer patients are more likely to develop severe
Coronavirus disease-2019 (COVID-19), which can cause mortality, as well as cancer …

The role of Eph receptors in cancer and how to target them: novel approaches in cancer treatment

OJ Buckens, B El Hassouni, E Giovannetti… - Expert opinion on …, 2020 - Taylor & Francis
Introduction Erythropoietin-producing human hepatocellular (Eph) receptors are among the
largest family of tyrosine kinases that are divided into two classes: EphA and EphB …

Targeting Eph/ephrin system in cancer therapy

A Lodola, C Giorgio, M Incerti, I Zanotti… - European journal of …, 2017 - Elsevier
It is well established that the Eph/ephrin system plays a central role in the embryonic
development, with minor implications in the physiology of the adult. However, it is …

CAR-based immunotherapy of solid tumours—a survey of the emerging targets

J Maher, DM Davies - Cancers, 2023 - mdpi.com
Simple Summary A rapidly emerging new approach to treat cancer involves collection of
patient immune white blood cells and genetic re-programming of the cells to express a new …

Inhibition of EphA3 expression in tumour stromal cells suppresses tumour growth and progression

ME Vail, RH Farnsworth, L Hii, S Allen, S Arora… - Cancers, 2023 - mdpi.com
Simple Summary We have identified the cell guidance receptor EphA3 on distinct
stromal/fibroblast-like cell types in the tumour microenvironment (TME) that promote growth …